NZ dollar rides optimism on unproven covid-19 treatment

NZ dollar rides optimism on unproven covid-19 treatment
Jenny Ruth
The New Zealand dollar rode a wave of optimism about a still-unproven covid-19 treatment which has been driving equities markets higher. At the same time, the market has been ignoring worse than expected US March-quarter GDP data and a downbeat economic assessment from the Federal Reserve. The kiwi was trading at 61.44 US cents at 5pm in Wellington from 60.93 cents at the same time yesterday. The trade-weighted index was at 69.11 from 68.78. Biopharmaceutical company Gilead has been talking up Remdesivir, a drug which proved ineffectiv...

More Markets

Rakon crashes to $10.4 million loss
Markets

Rakon crashes to $10.4 million loss

Revenue and profit slashed for the first half of 2025 financial year.

Halter proves it's a cash cow
Primary Sector

Halter proves it's a cash cow

The Deloitte Fast 50 winner's NZ unit reported chunky revenue and positive cash flow. 

Gentrack's plan for airport business to take flight
Markets

Gentrack's plan for airport business to take flight

Gentrack boss Gary Miles says its airport subsidiary is a unique global platform.